πŸ‡¨πŸ‡³ Country Profile

China

Expanding pharmaceutical supply to China

πŸ‡¨πŸ‡³ $286M
All data from DGCIS India export records (fiscal year, April–March).
$286M
Scale
China's healthcare system receives $286M in Indian pharmaceutical products each year β€” affordable, quality medicine.
64%
Medicine
Primarily medicine ingredients (64%), supplemented by medicines and traditional & herbal.
2.6Γ—
Trajectory
India's pharmaceutical supply to China has grown 2.6Γ— over the past decade β€” strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in China β€” building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $182M (63.6%) Medicines $80.7M (28.2%) Traditional & Herbal $16.2M (5.7%) Surgical & Hospital Supplies $7.0M (2.5%) Vaccines $0.24M (0.1%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in China Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into China: $23.6M across 14 filings (2011-2020).